6.38
3.77%
-0.25
Dopo l'orario di chiusura:
6.36
-0.02
-0.31%
Bioventus Inc Azioni (BVS) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-12-31 | 2023-09-30 | 2023-07-01 | 2023-04-01 | 2022-12-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
12.11%
135.42
|
120.79 | 137.07 | 119.06 | 125.83 |
Cost Of Revenue |
17.11%
49.12
|
41.94 | 47.95 | 45.14 | 51.65 |
Gross Profit |
9.45%
86.30
|
78.85 | 89.12 | 73.92 | 74.19 |
Operating Expenses
|
11.39%
85.14
|
76.43 | 82.37 | 165.98 | 99.62 |
Benefits Costs and Expenses |
11.51%
143.83
|
128.99 | 141.42 | 219.22 | 175.55 |
Costs And Expenses |
11.51%
143.83
|
128.99 | 141.42 | 219.22 | 175.55 |
Depreciation and Amortization |
9.28%
2.102
|
2.317 | 2.294 | 2.129 | 7.761 |
Operating Income/Loss |
51.82%
1.165
|
2.418 | 6.75 | -92.06 | -25.43 |
Nonoperating Income/Loss |
9.78%
-9.571
|
-10.61 | -11.10 | -8.106 | -24.28 |
Income/Loss From Continuing Operations Before Tax |
2.62%
-8.406
|
-8.191 | -4.35 | -100.16 | -49.71 |
Income Tax Expense/Benefit |
225.00%
-0.75
|
0.60 | 0.381 | -0.146 | -4.841 |
Income/Loss From Continuing Operations After Tax |
12.91%
-7.656
|
-8.791 | -4.731 | -100.02 | -44.87 |
Income/Loss From Discontinued Operations, Net Of Tax |
-
|
- | - | -74.43 | - |
Net Income/Loss
|
12.91%
-7.656
|
-8.791 | -4.731 | -174.45 | -44.87 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
4.84%
-1.56
|
-1.488 | -1.05 | -20.36 | -12.94 |
Basic Average Shares |
99.76%
0.1529
|
62.82 | 62.55 | 62.12 | 0.1802 |
Diluted Average Shares |
99.76%
0.1529
|
62.82 | 62.55 | 62.12 | 0.1802 |
Basic Earnings Per Share |
25.00%
-0.09
|
-0.12 | -0.06 | -2.24 | -0.52 |
Diluted Earnings Per Share |
25.00%
-0.09
|
-0.12 | -0.06 | -2.24 | -0.52 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):